Aclaris Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-1.60 | $-4.56 |
| FY2022 | $-1.33 | $-4.25 |
| FY2023 | $-1.27 | $-3.51 |
| FY2024 | $-1.71 | $-2.86 |
| FY2025 | $-0.53 | $-2.42 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-1.60 | $-4.56 |
| FY2022 | $-1.33 | $-4.25 |
| FY2023 | $-1.27 | $-3.51 |
| FY2024 | $-1.71 | $-2.86 |
| FY2025 | $-0.53 | $-2.42 |